A detailed history of Allworth Financial LP transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Allworth Financial LP holds 136 shares of NBIX stock, worth $17,100. This represents 0.0% of its overall portfolio holdings.

Number of Shares
136
Previous 234 41.88%
Holding current value
$17,100
Previous $32,000 53.13%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$114.58 - $153.15 $11,228 - $15,008
-98 Reduced 41.88%
136 $15,000
Q2 2024

Jul 23, 2024

BUY
$130.86 - $143.19 $19,105 - $20,905
146 Added 165.91%
234 $32,000
Q4 2023

Jan 24, 2024

BUY
$106.07 - $132.76 $3,394 - $4,248
32 Added 57.14%
88 $11,000
Q3 2023

Oct 31, 2023

SELL
$94.02 - $117.1 $1,786 - $2,224
-19 Reduced 25.33%
56 $6,000
Q2 2023

Jul 18, 2023

SELL
$89.53 - $104.87 $179 - $209
-2 Reduced 2.6%
75 $7,000
Q1 2023

Apr 18, 2023

BUY
$94.11 - $123.02 $2,352 - $3,075
25 Added 48.08%
77 $7,000
Q4 2022

Jan 13, 2023

SELL
$106.72 - $127.06 $106 - $127
-1 Reduced 1.89%
52 $0
Q3 2022

Oct 18, 2022

BUY
$92.03 - $107.81 $2,300 - $2,695
25 Added 89.29%
53 $6,000
Q2 2022

Jul 13, 2022

BUY
$75.79 - $100.07 $682 - $900
9 Added 47.37%
28 $3,000
Q1 2022

Apr 22, 2022

SELL
$72.45 - $94.81 $6,375 - $8,343
-88 Reduced 82.24%
19 $2,000
Q4 2021

Jan 21, 2022

SELL
$79.65 - $106.22 $1,354 - $1,805
-17 Reduced 13.71%
107 $9,000
Q3 2021

Nov 02, 2021

BUY
$86.18 - $99.03 $10,686 - $12,279
124 New
124 $12,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.